Ireland· IE-PA-EU/1/15/1015/003-004
Strensiq 100 mg/ml solution for injection
A enzymes product containing asfotase alfa, registered in Ireland by Alexion Europe SAS. The same ATC class is registered in 3 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Asfotase alfa is registered in 3 of 19 countries.
Countries holding a registration under ATC A16AB (enzymes), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 2 of them publish a price we can compare per daily dose
Asfotase alfa · ATC A16AB
3 / 19 countries
- Czechiaprice
- Icelandprice
- Ireland
The record
At a glance
HPRA (Ireland)- Active substance
- Asfotase alfa
- Manufacturer
- Alexion Europe SAS
- Country
- Ireland (IE)
- ATC code
- A16AB
- ATC class
- Enzymes
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/15/1015/003-004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Asfotase alfa in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FranceSTRENSIQ 100 mg/ml, solution injectableALEXION EUROPE
- NetherlandsStrensiq 100 mg/ml, oplossing voor injectieAlexion Europe SAS
- SwitzerlandStrensiq 100 mg/ml, InjektionslösungAlexion Pharma GmbH
- CzechiaSTRENSIQAlexion Europe SAS, Levallois-Perret
- BelgiumStrensiq 100 mg/mlAlexion Europe
- Japanアスホターゼ アルファ（遺伝子組換え）アレクシオンファーマ
- United StatesSTRENSIQAlexion Pharmaceuticals, Inc.
- CanadaSTRENSIQALEXION PHARMA GMBH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Strensiq
- Liechtenstein · Strensiq
- Norway · Strensiq
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d4bbee3f-d86e-4351-8be4-c0014c4777c7 GET /v1/drugs/d4bbee3f-d86e-4351-8be4-c0014c4777c7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Solution for injection",
"routes": [
"Subcutaneous use"
],
"source": "hpra",
"atc_all": [
"A16AB"
],
"strength": null,
"pa_number": "EU/1/15/1015/003-004",
"substances": [
"Asfotase alfa"
],
"legal_basis": "Full application (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": null,
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about asfotase alfa.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.